Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
Pfizer Starna deal infographic showing $330M upfront, $2.3B milestones and three in vivo CAR-T autoimmune programs
  • Industry Insights
57 minutes ago

Pfizer Starna Deal: $330M Upfront Buys Into In Vivo CAR-T for Autoimmune Disease

Pfizer is paying Starna Therapeutics $330 million upfront, with up to $2.3 billion in milestones, for three preclinical in vivo CAR-T programs in autoimmune disease. Terms, science and risks explained.

  • Isomorphic Labs Series C: Inside the $5 Billion Record Bet on AI-Designed Drugs
  • Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech
  • Illegal Vape Factory Raid: 850,000 Geek Bar and Foger Devices Found in California
Merck nemtabrutinib discontinued infographic: three Phase 3 BELLWAVE CLL trials stopped
  • Pharmaceuticals
20 hours ago

Merck Nemtabrutinib Discontinued: BELLWAVE CLL Program Ends After Safety Review

Merck ended all development of its non-covalent BTK inhibitor nemtabrutinib after a monitoring committee flagged benefit-risk concerns in Phase 3 BELLWAVE-011. The trials, the reasons and what comes next.

  • Leqembi Five-Year Data: Gap Versus Untreated Alzheimer’s Decline Keeps Widening
  • CagriSema Weight Loss: Early Responders Lose 25% in New REDEFINE 1 Analysis
  • Lilly ObesityWeek 2026 Data: EloraTZP Hits 23% Weight Loss, Retatrutide Tackles Sleep Apnea
Isomorphic Labs Series C infographic: $5 billion round, $7.7 billion raised and AI drug discovery market growth
  • Industry Insights
21 hours ago

Isomorphic Labs Series C: Inside the $5 Billion Record Bet on AI-Designed Drugs

Isomorphic Labs raised $5 billion in biotech’s largest private round. Who invested, how the money will be used and why clinical proof is still missing.

  • Pfizer Starna Deal: $330M Upfront Buys Into In Vivo CAR-T for Autoimmune Disease
  • Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech
  • Illegal Vape Factory Raid: 850,000 Geek Bar and Foger Devices Found in California
Flagship Pioneering London lab infographic: £100M commitment and AI drug discovery market data
  • Industry Insights
2 days ago

Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech

Flagship Pioneering commits £100M to a London Origination Lab to build AI-native biotech companies, its first outside the US, with a £500M partner target.

  • Pfizer Starna Deal: $330M Upfront Buys Into In Vivo CAR-T for Autoimmune Disease
  • Isomorphic Labs Series C: Inside the $5 Billion Record Bet on AI-Designed Drugs
  • Illegal Vape Factory Raid: 850,000 Geek Bar and Foger Devices Found in California
  • Industry Insights

Burial Insurance Market Revenue, Trends, and Strategic Insights by 2033

Megan Wood 57 minutes ago
  • Industry Insights

Cell Culture Protein Surface Coating Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 57 minutes ago
Pfizer Starna deal infographic showing $330M upfront, $2.3B milestones and three in vivo CAR-T autoimmune programs
  • Industry Insights

Pfizer Starna Deal: $330M Upfront Buys Into In Vivo CAR-T for Autoimmune Disease

Megan Wood57 minutes ago011 mins

Pfizer is paying Starna Therapeutics $330 million upfront, with up to $2.3 billion in milestones, for three preclinical in vivo CAR-T programs in autoimmune disease. Terms, science and risks explained.

Read More
Merck nemtabrutinib discontinued infographic: three Phase 3 BELLWAVE CLL trials stopped
  • Pharmaceuticals

Merck Nemtabrutinib Discontinued: BELLWAVE CLL Program Ends After Safety Review

Megan Wood20 hours ago09 mins

Merck ended all development of its non-covalent BTK inhibitor nemtabrutinib after a monitoring committee flagged benefit-risk concerns in Phase 3 BELLWAVE-011. The trials, the reasons and what comes next.

Read More
Isomorphic Labs Series C infographic: $5 billion round, $7.7 billion raised and AI drug discovery market growth
  • Industry Insights

Isomorphic Labs Series C: Inside the $5 Billion Record Bet on AI-Designed Drugs

Megan Wood21 hours ago010 mins

Isomorphic Labs raised $5 billion in biotech’s largest private round. Who invested, how the money will be used and why clinical proof is still missing.

Read More
Flagship Pioneering London lab infographic: £100M commitment and AI drug discovery market data
  • Industry Insights

Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech

Megan Wood2 days ago010 mins

Flagship Pioneering commits £100M to a London Origination Lab to build AI-native biotech companies, its first outside the US, with a £500M partner target.

Read More
Leqembi five-year data infographic with CDR-SB benefit and ARIA figures
  • Pharmaceuticals

Leqembi Five-Year Data: Gap Versus Untreated Alzheimer’s Decline Keeps Widening

Megan Wood2 days ago010 mins

Five years of continuous lecanemab left patients 2.05 CDR-SB points better than an untreated cohort, while ARIA risk fell after year one. What the CTAD 2026 data mean for Eisai and Biogen.

Read More
Illegal vape factory raid infographic with 850,000 vapes seized in Chino California
  • Industry Insights

Illegal Vape Factory Raid: 850,000 Geek Bar and Foger Devices Found in California

Megan Wood2 days ago010 mins

A previously undisclosed raid on an illegal vape factory in Chino, California, recovered about 850,000 Geek Bar and Foger vapes and parts. What it means.

Read More
Seawolf Therapeutics infographic showing $100M funding and Sanofi deal worth up to $1.2 billion
  • Industry Insights

Seawolf Therapeutics Launches With $100M and a Sanofi Deal to Make DNA Medicines Redosable

Megan Wood2 days ago010 mins

Seawolf Therapeutics debuts with $100M and a Sanofi pact worth up to $1.2B to develop non-viral DNA medicines for bleeding disorders. What TRIDENT promises and what is unproven.

Read More
Teva price-fixing settlement generic drugs infographic
  • Industry Insights

Teva Price-Fixing Settlement: 45 States Strike Deal in Generic Drug Collusion Case

Megan Wood2 days ago010 mins

Teva has reached an agreement in principle with 45 states, DC and two territories over alleged generic drug price-fixing. Terms are undisclosed; here is what is known.

Read More
Gedeon Richter Mayne Pharma acquisition infographic with A$6.40 offer and 99.4% premium
  • Industry Insights

Gedeon Richter Mayne Pharma Deal: A$604M Buys a US Women’s Health Platform

Megan Wood2 days ago010 mins

Gedeon Richter will pay A$6.40 a share, about A$604 million, for Mayne Pharma, a 99% premium that gives the Hungarian drugmaker a US women’s health business.

Read More
  • 1
  • 2
  • 3
  • …
  • 62

Categories

  • Healthcare IT (26)
  • Industry Insights (360)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (107)
  • Uncategorized (1)

Recent Posts

  • Pfizer Starna Deal: $330M Upfront Buys Into In Vivo CAR-T for Autoimmune Disease
  • Merck Nemtabrutinib Discontinued: BELLWAVE CLL Program Ends After Safety Review
  • Isomorphic Labs Series C: Inside the $5 Billion Record Bet on AI-Designed Drugs
  • Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech
  • Leqembi Five-Year Data: Gap Versus Untreated Alzheimer’s Decline Keeps Widening

You May Have Missed

Particle Therapy Market Revenue, Trends, and Strategic Insights by 2032
  • Industry Insights

Particle Therapy Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 7 months ago
Conjunctivitis Treatment Market Revenue, Trends, and Strategic Insights by 2032
  • Industry Insights

Conjunctivitis Treatment Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 7 months ago
Chlorpheniramine Maleate Market
  • Industry Insights

Chlorpheniramine Maleate Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 9 months ago
3D Bioprinting Market
  • Industry Insights

3D Bioprinting Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 10 months ago
Emcure FY27 guidance analysis after Q2 results with revenue growth above 20%
  • Pharmaceuticals

Emcure Pharma Q2 FY27 Results: Revenue Up 24.3% as International Business Surges and Guidance Rises

Megan Wood 2 weeks ago
Branded card reading Artificial Organs Market to Top 63 Billion Dollars by 2035 at 8.2 percent CAGR
  • Industry Insights
  • Medical Devices

Artificial Organs Market to Top $63 Billion by 2035

Megan Wood 2 months ago1 month ago
Graphic: Gilead cancer drug pipeline deal with Vir, showing $90 million upfront and $1.74 billion in milestones
  • Pharmaceuticals

Gilead Cancer Drug Pipeline Gets Bold Bet With Vir

Megan Wood 1 month ago1 month ago
Biomimetic Materials Market
  • Industry Insights

Biomimetic Materials Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 10 months ago
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.